1H-2,1,3-benzothiadiazine-2,2-dioxide compounds or derivatives thereof
US5929072A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Aug 21, 1998 |
| Grant date | Jul 27, 1999 |
| Priority date | — |
| Expiry date | Aug 21, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical compound having the formula: ##STR1## in which n is 1 or 2, m is 1 or 2, p is 1 to 6, q is 0 or 1 to 3, PA1 R.sup.1 and R.sup.2 are each hydrogen or C.sub.1-4 alkyl, PA1 R.sup.3, R.sup.4 and R.sup.5 are each hydrogen, C.sub.1-4 alkyl, optionally substituted phenyl or optionally substituted phenyl-C.sub.1-4 alkyl, or R.sup.3 and R.sup.4 together form an alkylene link of formula --(CH.sub.2).sub.3 -- or --(CH.sub.2).sub.4 --, or R.sup.4 and R.sup.5 together with the carbon atom to which they are attached form a C.sub.3-6 cycloalkyl group, PA1 R.sup.6 is C.sub.1-4 alkyl, C.sub.1-4 alkoxy, carboxy, hydroxy, cyano, halo, trifluoromethyl, nitro or amino, PA1 the dotted line represents an optional double bond, and PA1 the fluorine atom is attached at the 6 or 7-position; and salts and esters thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.